NCT06927804 Utilization of Virtual Reality to Increase Comfort and Reduce Procedural Distress During Port Insertion Into the Body
| NCT ID | NCT06927804 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Ostrava |
| Condition | Oncology Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-07-01 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomised controlled study evaluates whether virtual reality (VR) can support patient comfort and help reduce anxiety and stress during subcutaneous venous port implantation in adult oncology patients. Patients will be assigned to standard care or standard care with VR intervention. Subjective and objective measures of stress and discomfort will be collected, including the Visual Analog Scale (VAS) for self-reported procedural discomfort, physiological parameters (blood pressure, heart rate, variability), the STAI-6 questionnaire, and salivary cortisol. The study aims to explore the potential of VR as a non-pharmacological, immersive tool to improve procedural experience and reduce psychological distress in patients undergo-ing minor oncological procedures.
Eligibility Criteria
Inclusion Criteria: * Patients \> 18 years of age * Signed Informed Consent Form * Patients Indicated for oncology treatment administration using subcutaneous port Exclusion Criteria: * Not signing of the Informed Consent Form * Patients \< 18 years of age * Patients unsuitable for subcutaneous port implantation
Contact & Investigator
Lukáš Knybel, Ing., PhD
PRINCIPAL INVESTIGATOR
University Hospital Ostrava
Frequently Asked Questions
Who can join the NCT06927804 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oncology Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06927804 currently recruiting?
Yes, NCT06927804 is actively recruiting participants. Contact the research team at jiri.hyncica@fno.cz for enrollment information.
Where is the NCT06927804 trial being conducted?
This trial is being conducted at Ostrava, Czechia.
Who is sponsoring the NCT06927804 clinical trial?
NCT06927804 is sponsored by University Hospital Ostrava. The principal investigator is Lukáš Knybel, Ing., PhD at University Hospital Ostrava. The trial plans to enroll 60 participants.